CASI Pharmaceuticals, Inc (DE)
Biotechnology company · Rockville, Maryland, United States
CASI Pharmaceuticals, Inc (DE) is a biotechnology company headquartered in Rockville, Maryland, United States. It has received 6 US government small-business research awards (SBIR/STTR) from health agencies, $1.4 million in total, most recently in 2002. It has reported private securities offerings to the US SEC, most recently $10 million sold in a notice filed in 2012.
CASI Pharmaceuticals, Inc (DE) at a glance
What does CASI Pharmaceuticals, Inc (DE) do?
US government research funding
6 SBIR/STTR small-business research awards from US health agencies, $1.4 million in total (1994 to 2002).
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $10 million sold (2012).
Frequently asked questions about CASI Pharmaceuticals, Inc (DE)
Where is CASI Pharmaceuticals, Inc (DE) headquartered?
CASI Pharmaceuticals, Inc (DE) is headquartered in Rockville, Maryland, United States.
What does CASI Pharmaceuticals, Inc (DE) do?
CASI Pharmaceuticals, Inc (DE) is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Similar companies
- REGENXBIO Inc.Rockville, Maryland, United States
- Immunomic Therapeutics, Inc.Rockville, Maryland, United States
- OncoC4, Inc.Rockville, Maryland, United States
- Integrated Biotherapeutics LLCRockville, Maryland, United States
- Sanaria Inc.Rockville, Maryland, United States
- OncoImmune, Inc.Rockville, Maryland, United States
- Rise Therapeutics, LLCRockville, Maryland, United States
- KinaRx, Inc.Rockville, Maryland, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences